ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic Cancer.

Eric Van Cutsem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.